SLC2A4 and diabetes mellitus: Specifically, miR-223 is known to downregulate GLUT4 expression, which inhibits insulin-stimulated glucose uptake in adipocytes, suggesting its involvement in insulin resistance-related diseases such as type 2 diabetes mellitus (T2DM) and obesity [58].